...
首页> 外文期刊>Journal of general internal medicine >The Impact of Population-Based Disease Management Services on Health Care Utilisation and Costs: Results of the CAPICHe Trial
【24h】

The Impact of Population-Based Disease Management Services on Health Care Utilisation and Costs: Results of the CAPICHe Trial

机译:基于人口的疾病管理服务对医疗保健利用率的影响和成本:Capiche试验的结果

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundDisease management programmes may improve quality of care, improve health outcomes and potentially reduce total healthcare costs. To date, only one very large population-based study has been undertaken and indicated reductions in hospital admissions 10%.ObjectiveWe sought to confirm the effectiveness of population-based disease management programmes. The objective of this study was to evaluate the relative impact on healthcare utilisation and cost of participants the Costs to Australian Private Insurance - Coaching Health (CAPICHe) trial.DesignParallel-group randomised controlled trial, intention-to-treat analysisSettingAustralian populationParticipantsForty-four thousand four hundred eighteen individuals (18-90years of age) with private health insurance and diagnosis of heart failure, chronic obstructive pulmonary disease (COPD), coronary artery disease (CAD), diabetes, or low back pain, with predicted high cost claims for the following 12months.InterventionHealth coaching for disease management from Bupa Health Dialog, vs Usual Care.Main Outcome MeasuresTotal cost of claims per member to the private health insurer 1year post-randomisation for hospital admissions, including same-day, medical and prostheses hospital claims, excluding any maternity costs. Analysis was based on the intent-to-treat population.ResultsEstimated total cost 1year post-randomisation was not significantly different (means: intervention group A$4934; 95% CI A$4823-A$5045 vs control group A$4868; 95% CI A$4680-A$5058; p=0.524). However, the intervention group had significantly lower same-day admission costs (A$468; 95% CI A$454-A$482 vs A$508; 95% CI A$484-A$533; p=0.002) and fewer same-day admissions per 1000 person-years (intervention group, 530; 95% CI 508-552 vs control group, 614; 95% CI 571-657; p=0.002). Subgroup analyses indicated that the intervention group had significantly fewer admissions for patients with COPD and fewer same-day admissions for patients with diabetes.ConclusionsChronic disease health coaching was not effective to reduce the total cost after 12months of follow-up for higher risk individuals with a chronic condition. Statistically significant changes were found with fewer same-day admissions; however, these did not translate into cost savings from a private health insurance perspective.
机译:背景Disease管理计划可能会改善护理质量,提高健康结果,并可能降低总医疗费用。迄今为止,只开展了一个非常大的人口研究,并指出了医院入院的减少,并指出了10%。毒性我们试图确认基于人口的疾病管理计划的有效性。这项研究的目的是评估在医疗利用和参与者的成本,澳大利亚私人保险的成本相对影响 - 教练健康(CAPICHe)trial.DesignParallel组随机对照试验,意向性治疗analysisSettingAustralian populationParticipantsForty四个一千四百八人(18-90年龄)与私人健康保险和心力衰竭诊断,慢性阻塞性肺病(COPD),冠状动脉疾病(CAD),糖尿病或低腰疼痛,预测以下是以下的高成本声明12个月。从Bupa Health对话的疾病管理疾病管理,常规关心疾病管理,私人健康保险公司1年度索赔的结果MissoctOT索赔,包括当天,医疗和假体医院索赔,不包括任何产假。分析是基于意图的人口。估算总成本1年后期随机化没有显着差异(手段:干预组1美元4934美元; 95%CI $ 4868为4868美元。95%CI $ 4680 -A $ 5058; p = 0.524)。然而,干预组的票据录取成本明显较低(468美元; 95%CI为454美元-A $ 482 VS $ 508; 95%CI $ 484-A $ 533; P = 0.002)和每1000的同行录取时间较少人年(干预组,530; 95%CI 508-552 VS对照组,614; 95%CI 571-657; P = 0.002)。亚组分析表明,干预组对糖尿病患者的患者和较少的同日度录取患者的入学率明显较少。结合Chronic疾病疾病的疾病卫生教练无效,以减少12个月后的较高风险个体的后续行动后的总成本。慢性病。统计学上有显着的变化,较少的同日派入学;但是,这些并未从私人健康保险视角转化为节省成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号